USNA compared with DFTX: revenue, margins and what each company keeps, and the suppliers and customers both name

USNAUsana Health Sciences Inc

Mkt capRevenueRevenue

DFTXDefinium Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

USNAUsana Health Sciences Inc

DFTXDefinium Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only USNA 7

—State Administration of Market Regulation ("SAMR")unlistedsupplier

—Australian Therapeutic Goods Administration ("TGA")unlistedsupplier

—China Food and Drug Administrationunlistedsupplier

—Islamic Foods and Nutrition Counsel of Americaunlistedsupplier

3 more · USNA chain ›

Shared 0

No disclosed counterparties: DFTX.

Only DFTX 0

None

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

USNAUsana Health Sciences Inc

13.91▼−2.94%· post 13.91· delayed

Mkt cap$264.8MRevenue$223MQ2 FY26Revenue$925MFY25

DFTXDefinium Therapeutics, Inc.

30.34▼−7.21%· post 30.30· delayed

After hoursNov 5 '26delayed

Mkt cap$4.4BRevenue—Revenue—

Compare

After hoursNov 5 '26delayed

USNAUsana Health Sciences Inc

DFTXDefinium Therapeutics, Inc.

13.91▼−2.94%post 13.91delayed

Price

30.34▼−7.21%post 30.30delayed

$264.8M

Mkt cap

$4.4B

Q2 FY26$223M

Revenue

—

FY25$925M

Revenue

—

USNA13.91▼−2.94%vsDFTX30.34▼−7.21%After hoursNov 5 '26delayed